Tilray Inc (TLRY)
Healthcare
Drug Manufacturers - Specialty & Generic
4.60 $
+2.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -37 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21 | -40 | -22 | 42 | -48 | -57 | -5.1 | -20 | -1.8 | -12 | -22 | -37 | -73 | |
| 42 | 43 | 45 | 43 | 43 | 48 | 48 | 47 | 21 | 22 | 17 | 19 | 80 | |
| 8.3 | 8.2 | 8.1 | 7.3 | 6.9 | 7.2 | 4.0 | 6.1 | 6.9 | 17 | 14 | 15 | 53 | |
| 7.5 | -18 | -29 | 27 | -50 | -25 | 7.2 | -17 | -13 | -11 | -26 | -45 | -95 | |
| 5.6 | 7.8 | 13 | 13 | 9.1 | 7.6 | 20 | 9.4 | 13 | 14 | 3.9 | 10 | 41 | |
| -36 | 109 | 39 | 60 | -67 | -15 | 2.2 | 17 | 34 | -81 | 29 | -51 | -70 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | 0.0 | – | |
| – | – | – | – | -5.9 | -6.8 | -10 | -3.3 | -2.6 | -4.8 | -5.0 | -17 | -29 | |
| 19 | -114 | -16 | 11 | 82 | 53 | 21 | 26 | 27 | 67 | -4.3 | 68 | 159 | |
| -37 | -46 | 1.8 | 112 | -31 | -22 | 15 | 30 | 59 | -25 | 2.8 | -20 | 17 | |
| -27 | -48 | -35 | 30 | -57 | -64 | -25 | -29 | -15 | -25 | -26 | -48 | -114 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.